GAL3ST2 antisense RNA 1 (GAL3ST2-AS1)

GAL3ST2-AS1 (GAL3ST2 antisense RNA 1) refers to a putative long non-coding RNA located antisense to the *GAL3ST2* gene. Unlike GAL3ST2, which encodes a well-characterized sulfotransferase enzyme involved in glycan modification[1][3][4][5], there are no published data establishing GAL3ST2-AS1 as a functional biomolecule, a therapeutic target, or a molecule with a defined role in disease biology. The literature, databases, and gene annotations do not support its consideration as a classical or emerging drug target. Most relevant biological and disease relevance pertain to the sense (protein-coding) GAL3ST2 gene, not the antisense transcript. Essential context: If you intended to query the *protein-coding* target, all available therapeutic, biological, and pathophysiological information relates to **galactose-3-O-sulfotransferase 2 (GAL3ST2)**, a Golgi enzyme involved in glycan sulfation and implicated in cancer and cell adhesion[1][3][4][5]. GAL3ST2-AS1 may exist in gene databases as a locus, but is not an established therapeutic or biological target. Summary: GAL3ST2-AS1 (GAL3ST2 antisense RNA 1) is not an established therapeutic target, and all meaningful target information for "GAL3ST2" pertains to its protein-coding form. If you need structured information for galactose-3-O-sulfotransferase 2, please specify.

Other names

GAL3ST2 antisense RNA 1 (full name)GAL3ST2-AS1 (abbreviation)